Ankylosing Spondylitis Flashcards
Joints affected in AS
Sacroiliac joints
Vertebral column
causes pain and stiffness in these joints - can progress to fusion of the spine and sacroiliac joints (“bamboo spine”)
Link with HLA B27
90% of patients with AS have the HLA B27 gene
2% of people with the gene will get AS - around 20% if they have a first degree relative that is affected
Typical presentation of AS
Male - late teens or 20s
Symptoms develop gradually > 3 months
Lower back pain
Stiffness
Sacroiliac pain
Worse with rest and improves with movement
Worse at night and in the morning takes at least 30 minutes for the stiffness to improve
Symptoms can fluctuate with “flares”
Key complication of AS
Vertebral fractures
Associations with AS
weight loss
Fatigue
Anaemia
Anterior uveitis
Chest pain related to costovertebral and costosternal joints
Aortitis is inflammation of the aorta
Heart block can be caused by fibrosis of the heart’s conductive system
Restrictive lung disease can be caused by restricted chest wall movement
Pulmonary fibrosis at the upper lobes - 1% of AS patients
IBD
Enthesitis
Dactylitis
What is enthesitis?
Inflammation of the entheses
Tendons or ligaments insert in to bone
Can cause problems such as plantar fasciitis and achilles tendonitis
Schober’s Test
L5 vertebrae
10cm above and 5cm below
Distance with them bending forwards is less than 20cm = supports diagnosis of AS
Investigations in AS
CRP and ESR
HLA B27 genetic test
Xray of the spine and sacrum
MRI of the spine can show bone marrow oedema early in the disease before there are any xray changes
Xray changes
Fusion of the facet, sacroiliac and costovertebral joints
Bamboo spine
Ossification of the ligaments, discs and joints. This is where these structures turn to bone
Squaring of the vertebral bodies
Subchondral sclerosis and erosions
Syndesmophytes
What are syndesmophytes?
Areas of bone growth where the ligaments insert into the bone
Occur related to the ligaments supporting the intervertebral joints
Management of AS
NSAIDs
Steroids
Anti-TNF medications such as etanercept/ Mab
Secukinumab is a monoclonal antibody against interleukin-17. It is recommended by NICE if the response to NSAIDS and TNF inhibitors is inadequate.
Further management of AS (6)
Physiotherapy
Exercise and mobilisation
Avoid smoking
Bisphosphonates to treat osteoporosis
Treatment of complications
Surgery is occasionally required for deformities to the spine or other joints